NASP Controls Histone Turnover Behind PARP Resistance
The emergence of poly(ADP-ribose) polymerase inhibitors (PARPi) as a transformative therapy for homologous recombination-deficient tumors has significantly altered the landscape ...
The emergence of poly(ADP-ribose) polymerase inhibitors (PARPi) as a transformative therapy for homologous recombination-deficient tumors has significantly altered the landscape ...
In the relentless pursuit to decode the molecular underpinnings of cancer, the small nucleolar RNAs (snoRNAs) have emerged as compelling ...
At the forefront of oncology research, the University of Texas MD Anderson Cancer Center has unveiled a series of groundbreaking ...
In recent advances within the realm of cancer research, the University of Texas MD Anderson Cancer Center has showcased multiple ...
A recent publication details a compelling case study revolving around a patient diagnosed with stage IV non-small cell lung cancer ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine